imatge entitat
Societat Catalana d'Immunologia 
XV Congrés de la Societat Catalana d’Immunologia

25 i 26 de novembre de 2021 | Online | L'Acadèmia a Can Caralleu

25-11-2021 | Online | Online (Online)

16:00 - 16:15 Welcome to the XVth CONGRESS of the SCI

Presentador/a:  Pablo Engel Rocamora  

16:15 - 17:00 Opening Lecture:

Ponent:  Friedrich Koch-Nolte  

Moderador/a:  Pablo Engel Rocamora  

17:00 - 17:30 Company sponsored session Becton Dickinson

Flow Cytometric Monitoring of Anti CD 20 Therapies

Ponent:  Bruno Brando

17:30 - 18:00 Plenary Session - Cord blood as a starting material for advanced therapies

Moderador/a:  Ramón Gimeno  

Ponent:  Sergi Querol Giner  

18:00 - 20:00 Oral Communications I Basic Experimental Immunology

Moderador/a:  Jose Aramburu  

Moderador/a:  Francisco Lozano Soto  

OC1 IRF 1 is required for MDA 5 (IFIH 1 induction by IFN a, LPS and poly(I C) in murine macrophages Carlos

Ponent:  Carlos Batlle

OC 2 NK cells eliminate Epstein Barr virus bound to B cells through a specific antibody mediated uptake

Ponent:  Elisenda Alari

OC 3 Enforced sialyl Lewis X sLeX display in E selectin ligands by exofucosylation is dispensable for CD 19 CAR T cell activity and bone marrow homing.

Ponent:  Diego Sánchez

OC 4 HEK 293 F cell line shows different antigen presentation features than HEK 293

Ponent:  Alba Pastor

26-11-2021 | Online | Online (Online)

09:00 - 09:30 Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells

Moderador/a:  Francesc Rudilla  

Ponent:  joaquim Vives Armengol  

09:30 - 11:30 Oral Communications II Autoimmunity and Clinical Immunology

Moderador/a:  Clara Franco Jarava  

Moderador/a:  Odette Viñas  

OC 5 Association of HLA B* 35 and severe hypersensitivity reactions secondary to benznidazole treatment in chronic Chagas disease patients.

Ponent:  Pau Bosch

OC 6 Limitations of commercial assays as diagnostic tests of autoimmune encephalitis.

Ponent:  Guillermo Muñoz

OC 7 Dacmecitos study Influence of the type of donation on the inflammatory pattern in lung transplantation.

Ponent:  Alberto Sandiumenge Camps

OC 8 Anti Th/To auto antibodies in patients with SSc are the commercial assays good enough?

Ponent:  Janire Perurena

OC 9 Interaction between humoral and cutaneous immune response to Candida albicans in plaque psoriasis.

Ponent:  Lídia Sans de San Nicolás

OC 10 Peripheral Blood Lymphocyte Subsets at diagnosis of Arthritis in the Elderly differences between elderly onset rheumatoid arthritis and polymyalgia rheumatic.

Ponent:  Aina Teniente Serra

11:30 - 12:00 Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells

Ponent:  James Hutchinson  

Moderador/a:  Carles Serra  

12:00 - 12:45 Company sponsored lunch session I Beckman Coulter

Ponent:  Michael Kapinsky  

Unmasked Targets, Retired Pipettes, Uncharged Sorting And Other Beckman Coulter Innovations In Flow Cytometry

12:45 - 13:15 Company sponsored lunch session II Miltenyi Biotec

Ponent:  Daniel Schäfer  

Identification of CAR target candidates against pancreatic adenocarcinoma using ultra high content imaging

13:15 - 14:15 Ordinary General Meeting Societat Catalana d’Immunologia

14:15 - 16:30 Oral Communications III Tumor Immunology Immunotherapy

Moderador/a:  Alena Gros  

Moderador/a:  Sonia Guedan  

OC 11 MYC inhibition by an Omomyc based therapy abrogates tumor progression and induces immune cell recruitment in models of NSCLC.

Ponent:  Sílvia Casacuberta

OC 12 ARI 0001 autorització sota exempció Hospitalària com emprar productes d'immunoteràpia autoritzats després d'un assaig clínic exitòs.

Ponent:  Manel Juan Otero

OC 13 Optimizing a FAP CAR T cell for clinical trials.

Ponent:  Estela Ortega

OC 14 Pre leukemic CD 34 +CD 19 CD 22 early B cell progenitors might underlie phenotypic escape in patients treated with CD 19 directed immunotherapies.

Ponent:  Clara Bueno

OC 15 A novel and efficient tandem CD 19 and CD 22 directed CAR for B cell ALL.

Ponent:  Talia Velasco

OC 16 DIF peptides, a new approach to cancer immunotherapy Preliminary studies.

Ponent:  Marta Corral

OC 17 CD 137 costimulation counteracts TGF B inhibition of NK cell anti tumor function.

Ponent:  Aura Muntasell et

15:55 - 16:30 Discussion

16:45 - 19:00 Oral Communications IV COVID 19

Moderador/a:  Jorge Carrillo  

Moderador/a:  Gemma Moncunill  

OC 18 SARS CoV 2 sculpts the immune system to induce sustained virus specific naïve like and memory B cell responses.

Ponent:  Giuliana Magri

OC 19 Clinical course impacts early kinetics and long term magnitude and amplitude of SARS CoV 2 neutralizing antibodies beyond one year after infection.

Ponent:  Edwar Pradenas

OC 20 Determinants of early antibody responses to COVID 19 mRNA vaccines in exposed and naive healthcare workers.

Ponent:  Gemma Moncunill

OC 21 A new flow cytometry cell based assay to efficiently determine RBD specific neutralization of SARS CoV 2 emerging variants.

Ponent:  Pablo Hernández

OC 22 Analysis of Clinical and Laboratory Markers Based on the First COVID 19 Wave in Barcelona Limitations of the Current Clinicopathological Tests Guides the Identification of Effective Biomarkers.

Ponent:  Ricardo Pujol Borrell

OC 23 High dose intravenous immunoglobulins might modulate inflammation in COVID 19 patients.

Ponent:  Erola Ainsua

OC 24 SARS CoV 2 antibody kinetics in healthcare workers in northern metropolitan Barcelona.

Ponent:  Marc Boigues Pons

19:00 - 19:30 Plenary Session - Regulatory T cells in Autoimmune diseases

Ponent:  Piotr Trzonzowski  

Moderador/a:  Eva Martínez Cáceres  

19:30 - 19:45 Prize to the best communication and poster. Closing of the Congress

Ponent:  Eva Martínez Cáceres